Retour
Également cotée sous
SAUHF
OTC
Fourchette du Jour
9,60 €
9,82 €
Fourchette 52 Semaines
9,44 €
14,18 €
Volume
21 350
Moyenne 50J / 200J
11,79 €
/
12,00 €
Clôture Précédente
9,45 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 45,1 | 0,4 |
| P/B | 7,1 | 2,9 |
| ROE % | 16,3 | 3,7 |
| Net Margin % | 13,7 | 3,9 |
| Rev Growth 5Y % | 5,3 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,54 €
0,53 € – 0,56 €
|
4,1 B | 1 |
| FY2029 |
0,46 €
0,46 € – 0,48 €
|
3,7 B | 1 |
| FY2028 |
0,42 €
0,42 € – 0,44 €
|
3,3 B | 1 |
Points Clés
Revenue grew 5,32% annually over 5 years — modest growth
Earnings declined -11,95% over the past year
ROE of 16,27% — decent returns on equity
Debt/Equity of 0,30 — conservative balance sheet
Generating 314,96M in free cash flow
P/E of 45,05 — premium valuation
Croissance
Revenue Growth (5Y)
5,32%
Revenue (1Y)-0,64%
Earnings (1Y)-11,95%
FCF Growth (3Y)-5,44%
Qualité
Return on Equity
16,27%
ROIC13,97%
Net Margin13,74%
Op. Margin21,07%
Sécurité
Debt / Equity
0,30
Current Ratio2,21
Interest Coverage0,00
Valorisation
P/E Ratio
45,05
P/B Ratio7,12
EV/EBITDA29,71
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,64% | Revenue Growth (3Y) | 1,56% |
| Earnings Growth (1Y) | -11,95% | Earnings Growth (3Y) | 17,88% |
| Revenue Growth (5Y) | 5,32% | Earnings Growth (5Y) | -3,61% |
| Profitability | |||
| Revenue (TTM) | 2,49B | Net Income (TTM) | 341,91M |
| ROE | 16,27% | ROA | 8,95% |
| Gross Margin | 68,60% | Operating Margin | 21,07% |
| Net Margin | 13,74% | Free Cash Flow (TTM) | 314,96M |
| ROIC | 13,97% | FCF Growth (3Y) | -5,44% |
| Safety | |||
| Debt / Equity | 0,30 | Current Ratio | 2,21 |
| Interest Coverage | 0,00 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 45,05 | P/B Ratio | 7,12 |
| P/S Ratio | 6,19 | PEG Ratio | -3,99 |
| EV/EBITDA | 29,71 | Dividend Yield | 0,01% |
| Market Cap | 15,40B | Enterprise Value | 15,58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,49B | 2,50B | 2,41B | 2,32B | 2,02B |
| Net Income | 341,91M | 388,32M | 246,07M | 434,79M | 396,08M |
| EPS (Diluted) | 0,21 | 0,24 | 0,15 | 0,27 | 0,25 |
| Gross Profit | 1,71B | 1,78B | 1,79B | 1,70B | 1,53B |
| Operating Income | 524,32M | 601,00M | 410,97M | 535,35M | 542,58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,82B | 3,62B | 3,40B | 3,45B | 3,05B |
| Total Liabilities | 1,65B | 1,58B | 1,56B | 1,60B | 1,55B |
| Shareholders' Equity | 2,16B | 2,04B | 1,84B | 1,85B | 1,50B |
| Total Debt | 651,46M | 413,89M | 412,35M | 781,61M | 706,57M |
| Cash & Equivalents | 475,97M | 375,49M | 410,31M | 696,10M | 880,42M |
| Current Assets | 1,65B | 1,52B | 1,39B | 1,59B | 1,53B |
| Current Liabilities | 744,45M | 943,16M | 714,18M | 972,10M | 562,63M |